What We're Reading: Page 231
Industry reads hand-picked by our editors
May 01, 2019
Apr 30, 2019
-
The Washington Post
Why Vermont's single-payer effort failed and what Democrats can learn from it
-
In the Pipeline
The Going Rates, 2019 Edition
-
CNN
Our antibiotics are no match for superbugs, and it's a 'global crisis,' UN report says
-
Reuters
Novartis's Sandoz strikes deal for biosimilar of Herceptin
Apr 29, 2019
-
The Wall Street Journal
Cancer-drug giant Roche loses edge as rivals grow
-
Kaiser Health News
Is insulin's high cost keeping diabetes patients from taking their medicine?
-
Bloomberg
Snoop Dogg-backed medical weed firm seeks big pharma funding
-
Reuters
The obscure advisory committees at the heart of the U.S. drug pricing debate
Apr 26, 2019
Apr 25, 2019
Apr 24, 2019
Apr 23, 2019
-
The New York Times
How to Raise a Trillion Dollars
-
Xconomy
Can We Afford to Be Cured? A Conversation With ICER's Steve Pearson
-
Regulatory Focus
How Biopharma Companies Use NIH and Vice Versa
-
Vox
No one knows what Joe Biden thinks about health care
Previous
